Yi Ling Lai

1.6k total citations · 1 hit paper
32 papers, 1.1k citations indexed

About

Yi Ling Lai is a scholar working on Epidemiology, Applied Microbiology and Biotechnology and Infectious Diseases. According to data from OpenAlex, Yi Ling Lai has authored 32 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Applied Microbiology and Biotechnology and 7 papers in Infectious Diseases. Recurrent topics in Yi Ling Lai's work include Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Mycobacterium research and diagnosis (5 papers). Yi Ling Lai is often cited by papers focused on Antibiotic Use and Resistance (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Mycobacterium research and diagnosis (5 papers). Yi Ling Lai collaborates with scholars based in United States, China and Poland. Yi Ling Lai's co-authors include Sameer S. Kadri, Jennifer Adjemian, Emily Ricotta, Robert L. Danner, D. Rebecca Prevots, John P. Dekker, John H. Powers, Chanu Rhee, Michael Klompas and Tara N. Palmore and has published in prestigious journals such as Nature Communications, Advanced Drug Delivery Reviews and Clinical Infectious Diseases.

In The Last Decade

Yi Ling Lai

31 papers receiving 1.0k citations

Hit Papers

Difficult-to-Treat Resistance in Gram-negative Bacteremia... 2018 2026 2020 2023 2018 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents
    2018 377 citations Sameer S. Kadri, Jennifer Adjemian et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yi Ling Lai United States 14 434 392 347 252 219 32 1.1k
Grace C. Lee United States 17 271 0.6× 328 0.8× 201 0.6× 339 1.3× 167 0.8× 41 1.1k
Maristela Pinheiro Freire Brazil 23 545 1.3× 511 1.3× 168 0.5× 189 0.8× 95 0.4× 71 1.3k
Hae Suk Cheong South Korea 18 350 0.8× 430 1.1× 140 0.4× 289 1.1× 104 0.5× 52 1.0k
Alessia Carnelutti Italy 16 229 0.5× 325 0.8× 134 0.4× 288 1.1× 186 0.8× 42 833
Nancy M. Laing Canada 15 446 1.0× 718 1.8× 137 0.4× 261 1.0× 168 0.8× 20 1.2k
Nazaret Cobos-Trigueros Spain 14 269 0.6× 241 0.6× 180 0.5× 152 0.6× 192 0.9× 21 617
Michael P. Veve United States 17 319 0.7× 330 0.8× 163 0.5× 305 1.2× 124 0.6× 76 925
Margaret A. Fitzpatrick United States 16 283 0.7× 255 0.7× 185 0.5× 145 0.6× 104 0.5× 72 743
Ya‐Sung Yang Taiwan 22 569 1.3× 433 1.1× 126 0.4× 253 1.0× 119 0.5× 84 1.2k
Cesira Giordano Italy 14 698 1.6× 229 0.6× 294 0.8× 129 0.5× 205 0.9× 29 999

Countries citing papers authored by Yi Ling Lai

Since Specialization
Citations

This map shows the geographic impact of Yi Ling Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ling Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ling Lai more than expected).

Fields of papers citing papers by Yi Ling Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ling Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ling Lai. The network helps show where Yi Ling Lai may publish in the future.

Co-authorship network of co-authors of Yi Ling Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Ling Lai. A scholar is included among the top collaborators of Yi Ling Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Ling Lai. Yi Ling Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Ping, Jiaxing Pan, Bo Peng, et al.. (2025). Smart drug delivery platforms reprogramming cancer immune cycle to mitigate immune resistance of pancreatic tumors. Advanced Drug Delivery Reviews. 224. 115620–115620. 2 indexed citations
2.
Gao, Jing, Xingyu Jiang, Yi Ling Lai, et al.. (2024). A region-confined PROTAC nanoplatform for spatiotemporally tunable protein degradation and enhanced cancer therapy. Nature Communications. 15(1). 6608–6608. 37 indexed citations
3.
Lai, Yi Ling, Hongmei Liu, He Li, et al.. (2023). A diagnostic model based on DNA methylation haplotype block characteristics for identifying papillary thyroid carcinoma from thyroid adenoma. Translational research. 264. 76–84. 1 indexed citations
4.
Yuan, Jialing, Yi Ling Lai, & Tao Li. (2022). Ovarian protection and safety of gonadotropin-releasing hormone agonist after cervical cancer surgery: systematic review and meta-analysis. Annals of Translational Medicine. 10(7). 409–409. 6 indexed citations
5.
Babiker, Ahmed, Xiaobai Li, Yi Ling Lai, et al.. (2020). Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. The Lancet Infectious Diseases. 21(5). 697–710. 55 indexed citations
6.
7.
Strich, Jeffrey R., Sarah Warner, Yi Ling Lai, et al.. (2020). Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study. The Lancet Infectious Diseases. 20(10). 1172–1181. 25 indexed citations
8.
Kadri, Sameer S., Yi Ling Lai, Emily Ricotta, et al.. (2019). External Validation of Difficult-to-Treat Resistance Prevalence and Mortality Risk in Gram-Negative Bloodstream Infection Using Electronic Health Record Data From 140 US Hospitals. Open Forum Infectious Diseases. 6(4). ofz110–ofz110. 42 indexed citations
9.
Lai, Yi Ling, et al.. (2019). Dwindling Utilization of Central Venous Catheter Tip Cultures: An Analysis of Sampling Trends and Clinical Utility at 128 US Hospitals, 2009–2014. Clinical Infectious Diseases. 69(10). 1797–1800. 10 indexed citations
10.
Lai, Yi Ling, Emily Ricotta, Kenneth N. Olivier, Sameer S. Kadri, & D. Rebecca Prevots. (2019). 1382. Acid-Fast Bacilli Testing Trends at 43 In- and Outpatient Facilities and Nontuberculous Mycobacterial Pulmonary Isolation Rate, United States, 2009–2015. Open Forum Infectious Diseases. 6(Supplement_2). S502–S502. 1 indexed citations
11.
Strich, Jeffrey R., Emily Ricotta, Yi Ling Lai, et al.. (2018). 2398. Utilization Practices of Ceftazidime–Avibactam at Academic Medical Centers in the United States. Open Forum Infectious Diseases. 5(suppl_1). S715–S716. 1 indexed citations
12.
Mu, Liangshan, R. Li, Yi Ling Lai, Yue Zhao, & Jie Qiao. (2018). Adipose insulin resistance is associated with cardiovascular risk factors in polycystic ovary syndrome. Journal of Endocrinological Investigation. 42(5). 541–548. 21 indexed citations
13.
Ricotta, Emily, Kenneth N. Olivier, Yi Ling Lai, D. Rebecca Prevots, & Jennifer Adjemian. (2018). Hospital-based antibiotic use in patients withMycobacterium aviumcomplex. ERJ Open Research. 4(4). 109–2018. 4 indexed citations
14.
Kadri, Sameer S., Jennifer Adjemian, Yi Ling Lai, et al.. (2018). Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents. Clinical Infectious Diseases. 67(12). 1803–1814. 377 indexed citations breakdown →
15.
Ricotta, Emily, Yi Ling Lai, Sameer S. Kadri, et al.. (2018). 362. Species Distribution and Trends of Invasive Candidiasis in the United States, 2009–2015, Using a Large Electronic Medical Record Database. Open Forum Infectious Diseases. 5(suppl_1). S142–S142. 2 indexed citations
16.
Spaulding, Alicen B., Yi Ling Lai, Adrian M. Zelazny, et al.. (2017). Geographic Distribution of Nontuberculous Mycobacterial Species Identified among Clinical Isolates in the United States, 2009–2013. Annals of the American Thoracic Society. 14(11). 1655–1661. 68 indexed citations
17.
Liu, Zhiying, et al.. (2017). [Clinical manifestation and cytogenetic analysis of 607 patients with Turner syndrome].. PubMed. 34(1). 61–64. 3 indexed citations
18.
Kadri, Sameer S., Alicen B. Spaulding, Yi Ling Lai, et al.. (2016). Difficult-to-Treat Resistance: A Novel Antimicrobial Resistance Classifier That Reliably Predicts Outcome in Gram-Negative Bloodstream Infections. Open Forum Infectious Diseases. 3(suppl_1). 1 indexed citations
19.
Zhang, Jianjun, Xinlian Chen, Gang Shi, et al.. (2013). Establishment of a new representative model of human ovarian cancer in mice. Journal of Ovarian Research. 6(1). 9–9. 6 indexed citations
20.
Lin, Chun Chi, et al.. (2011). Clinicopathologic features and prognostic analysis of MSI-high colon cancer. International Journal of Colorectal Disease. 27(3). 277–286. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Grace C. Lee Breakdown of academic impact, for papers by Maristela Pinheiro Freire Breakdown of academic impact, for papers by Hae Suk Cheong Breakdown of academic impact, for papers by Alessia Carnelutti Breakdown of academic impact, for papers by Nancy M. Laing Breakdown of academic impact, for papers by Nazaret Cobos-Trigueros Breakdown of academic impact, for papers by Michael P. Veve Breakdown of academic impact, for papers by Margaret A. Fitzpatrick Breakdown of academic impact, for papers by Ya‐Sung Yang Breakdown of academic impact, for papers by Cesira Giordano
Rankless by CCL
2026